Impact Factor
2.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.29
158 total citations
h5-index
19
h5 depth signal
Cited share
46.8%
59 of 126
Total citations
158
Citation footprint
Metric signal
1.34
External metric anchor
Self-citation
12.0%
19 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
550
United Kingdom
18
Australia
18
Canada
15
Sweden
9
Citing Fields of Research
Pharmacology & Toxicology
304
Substance Abuse
148
Anesthetic & Pain Medicine
96
Healthcare Policy
41
Nutraceuticals
39
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,354
Articles tracked across the journal lifetime
Indexed publication set
126
59 cited publications
Last 12 months
63
5.3 publications/month
Open access share
30.2%
19 OA publications in the last year
Leading citing country
United States
550 citing publications
Leading citing field
Pharmacology & Toxicology
304 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Dec. 2005-
v1n1, Dec. 2005-
Active Coverage
Research Focus & Classification
Indexed Subjects
Pharmacology & Toxicology
Substance Abuse
Anesthetic & Pain Medicine
Issuing & Sponsoring Bodies
Contributor
American College of Medical Toxicology
Broad Categories
Toxicology
Substance Abuse
Pharmacology & Toxicology
Nutraceuticals
MeSH Descriptors
Toxicology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s13181-026-01162-4
Open DOI
Articles You Might Have Missed
02
03
DOI 10.1007/s13181-026-01152-6
Open DOI
Examining Trends in Early Childhood Lead Exposure Using the National Poison Data System: 2007–2024
04
DOI 10.1007/s13181-026-01160-6
Open DOI
Acrodynia and CASPR2 Autoimmunity in Elemental Mercury Toxicity
05
DOI 10.1007/s13181-026-01159-z
Open DOI
Adult U.S. Poison Center Exposure Case Trends Involving Nonprescription Dextromethorphan Amid the COVID-19 Pandemic: a Quasi-experimental Interrupted Time Series Study
Introduction Nonprescription dextromethorphan (DXM) is widely available in the United States and was commonly recommended for managing dry cough associated with COVID-19. This retrospective study of Poison Center data evaluated whether t...
06
07
DOI 10.1007/s13181-026-01156-2
Open DOI
Octreotide Administration Methods in Sulfonylurea Poisoning: A Retrospective Chart Review
08
DOI 10.1007/s13181-026-01158-0
Open DOI
Therapeutic Medication Errors in the Non-Healthcare Facility Setting Associated with Hospital Admission, 2000–2024
Introduction: This study investigated the characteristics and trends of therapeutic medication errors reported to United States (US) poison centers that occurred in a non-healthcare facility setting and were associated with hospital admi...
09
DOI 10.1007/s13181-026-01155-3
Open DOI
ACMT Position Statement: Preventing Cannabis Exposures in Children (2026)
10
DOI 10.1007/s13181-026-01151-7
Open DOI
Systematic Review and Meta-Analysis of Lipid Emulsion for Non-Local Anesthetic Poisoning
Introduction: Practitioners routinely use intravenous lipid emulsion for local anesthetic systemic toxicity, but its role in non-local anesthetic poisonings remains unclear. We conducted a systematic review and meta-analysis comparing li...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with 2013.
Also issued online.
v. 1, no. 1 (Dec. 2005)20080103 Notice not published Printed on acid-free paper